Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa
| Autor: | Stephen Sarfo, Lambert Tetteh Appiah, David Chadwick, Geraldine M. Foster, Uli Schwab, Richard Phillips, Alastair Stanley, AM Geretti, Michael Ankcorn |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
HBsAg medicine.medical_specialty Anti-HIV Agents Immunology HIV Infections Ghana Body Mass Index Internal medicine Prevalence medicine Humans Immunology and Allergy Hepatitis B Surface Antigens Coinfection business.industry virus diseases Lamivudine Viral Load Hepatitis B medicine.disease Occult Antiretroviral therapy digestive system diseases CD4 Lymphocyte Count Treatment Outcome Infectious Diseases Disease Progression Reverse Transcriptase Inhibitors Female business Body mass index Viral load medicine.drug |
| Zdroj: | AIDS. 27:139-141 |
| ISSN: | 0269-9370 |
| DOI: | 10.1097/qad.0b013e3283589879 |
| Popis: | This study evaluated the outcome of first-line antiretroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV co-infection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|